1.Clinical analysis of allogeneic peripheral blood stem cell transplantation for 95 patients with acute lymphoblastic leukemia
Qiaochuan LI ; Zhongming ZHANG ; Lianjin LIU ; Yizhen ZHOU ; Yongrong LAI
Chinese Journal of Organ Transplantation 2015;36(2):82-86
Objective To analyze the outcomes and the prognostic factors of allogeneic peripheral blood stem cell transplantation (allo-PBSCT) for acute lymphoblastic leukemia (ALL).Method From Feb.2002 to Feb.2014,a total of 95 patients with ALL were treated with alloPBSCT in our hospital.Of these,73 cases obtained the first CR (CR1),11 cases obtained late CR,7 patients were in relapse and 3 patients suffered from primarily refractory disease (PRD) before transplant.The median age was 26 (4-57) years.Conditioning regimens including total body irradiation (TBI)/ etoposide/semustine/cyclophosphamide or busulfan/semustine/cyclophosphamide were used.Matched sibling transplantation was performed on 68 patients,and matched unrelated donor transplantation was performed on 27 patients.Combination of CsA,MTX and low-dose,short-course mycophenolate mofetil was used for graft-versus-host disease (GVHD) prophylaxis.The average fellow-up was 57 months.Result Hematopoietic reconstitution was achieved in all 95 patients.Five-year estimate of overall survival (OS) was 54.3%,disease free survival (DFS) was 51.2%,relapse rate (RR) was 30.2% and transplant-related mortality (TRM) was 24.0%.The 5 year OS and DFS were significantly longer in patients with CR1 than in late CR and relapse/PRD patients before allo-PBSCT (P<0.001).There was no significant difference in OS between the two different conditioning regimens.Multivariate analyses revealed that Ⅱ-Ⅳ aGVHD and cGVHD were correlated with higher TRM,CR1 before allo-PBSCT and TBI were associated with a lower RR,and non Ⅱ-Ⅳ aGVHD and CR1 before allo-PBSCT were favorable factors which were associated with OS and DFS.In the patients with DFS≥1 year after allo-PBSCT,DFS and OS were shorter in patients with cGVHD (P =0.008).Conclusion Allo-PBSCT in adult ALL patients should be performed in CR1.Severe acute and chronic GVHD are not associated with improved survival.
2.Expression of tissue factor in cerebral microvascular thrombosis in rats
Wei ZHOU ; Yu HU ; Huafang WANG ; Lianjin LIU ; Yadan WANG ; Jine ZHENG ; Wenning WEI
Chinese Journal of Pathophysiology 2000;0(11):-
AIM: To study the expression of tissue factor (TF) in cerebral microvascular thrombosis and its dynamic changes in rats. METHODS: 50 female SD rats were randomized to control group, 2, 4, 6, and 24 hours after thrombosis groups, 10 rats in each group. The model of cerebral microvascular thrombosis was induced by photo-chemical method. ELISA and immunohistochemistry methods were used to observe the changes of TF contents in blood plasma and the expression of TF in cerebral microvascular in each group. RESULTS: Cerebral thrombosis was induced by photo-chemical method successfully. The TF content in plasma was obviously higher in 4 h and 6 h groups than that in control group (P
3. Clinical analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in thalassemia major
Zhongming ZHANG ; Yongrong LAI ; Qiaochuan LI ; Lin LUO ; Rongrong LIU ; Lingling SHI ; Lianjin LIU
Chinese Journal of Hematology 2018;39(11):908-911
Objective:
To explore the diagnosis, treatment and prognosis of autoimmune hemolytic anemia (AIHA) after allo-HSCT in patients with thalassemia major (TM).
Methods:
A retrospective analysis of AIHA status after allo-HSCT in 291 TM patients from July 2007 to December 2017 was conducted.
Results:
Five of the 291 TM patients (1.72%) were diagnosed with post-transplant AIHA. The median time of AIHA was 7 (5-12) months after HSCT. All post-transplant AIHA patients were positive in direct and indirect Coombs test, the main clinical manifestations were dizziness, fatigue, pale complexion, skin and sclera yellow, and soy sauce urine. The incidence of AIHA was higher after unrelated donor transplantation (6.36%, 4/63) compared with that of sibling donor transplantation (0.43%, 1/228). One patient who received only prednison was dead. Four patients who received rituximab combined with prednisolone were alive, Coombs test in two of them were negative.
Conclusions
AIHA after allo-HSCT developed in 1.72% patients with TM. Monitoring of Coombs test was important for diagnosis of post-transplant AIHA. The incidence of post-transplant AIHA was higher in unrelated donors compared with that of sibling donors transplantation. Treatment of rituximab combined glucocorticoid was effective strategy for post-transplant AIHA.
4.A clinical analysis of hepatic veno-occlusive disease after hematopoietic stem cell transplantation
Chunjie QIN ; Lianjin LIU ; Zhongming ZHANG ; Lin LUO ; Yongrong LAI ; Qiaochuan LI
Chinese Journal of Internal Medicine 2018;57(7):483-486
Objective To analyze the outcome and the prognostic factors of hepatic veno-occlusive disease (HVOD) after hematopoietic stem cell transplantation (HSCT). Methods A total of 797 patients receiving HSCT were analyzed retrospectively. The prophylaxis regimen of HVOD in the First Affiliated Hospital of Guangxi Medical University consisted of low molecular weight heparin and lipoprostaglandin E1 (PGE1). Results Fifty-nine patients (7.4%) developed HVOD at 3-49 days after HSCT (median 12 days). Age younger than 15 years at transplant( HR=6.47, P<0.001), busulphan conditioning ( HR=6.40, P<0.001), thalassemia major ( HR=6.35,P<0.001), allogeneic transplantation ( HR=7.74, P=0.005) were univariate risk factors for HVOD. Multivariate analyses suggested that thalassemia major and busulphan conditioning were independently correlated with the development of HVOD. Conclusion Thalassemia major and busulphan conditioning are independent risk factors for HVOD after HSCT.
5.Application of digital classroom based on identifying sectional structure in the experimental teaching of sectional anatomy
Ping SUN ; Zengmian WANG ; Ning AN ; Lianjin JIN ; Cheng SUN ; Jing ZHANG ; Junfeng LIU
Chinese Journal of Medical Education Research 2023;22(10):1510-1513
Objective:To discuss the application effect of digital classroom based on identifying sectional structure in the experimental teaching of sectional anatomy.Methods:A total of 180 students majoring in imaging diagnosis from six classes of Batch 2018 in Mudanjiang Medical University were randomly selected as the research objects and divided into the experimental group and the control group. Three classes (90 people) in the experimental group implemented the digital classroom teaching of learning platform + virtual digital person, while another three classes (90 people) in the control group adopted traditional teaching. After the course, the effect was evaluated according to the results of the questionnaire and the final exam results. SPSS 18.0 software was used for t-test and Chi-square test. Results:The questionnaire showed that the students in the experimental groups were superior to those in the control group in self-study ability, independent thinking ability, analytical and problem-solving ability, learning efficiency, learning interest and sectional thinking cultivation, and the difference was statistically significant ( P<0.05). The test scores showed that the theoretical scores [(56.08±1.65) vs. (45.19±1.74)], experimental scores [(37.13±3.24) vs. (30.16±2.04)] and total scores [(93.21±3.18) vs. (75.35±1.79)] in the experimental group were higher than those in control group, and the differences were statistically significant ( P<0.05). Conclusion:The digital classroom based on identifying sectional structure is a feasible teaching mode, which improves the students' ability to analyze and solve problems, increases their interest in sectional anatomy, and improves the teaching effect.
6.Predictive value of peripheral blood CD34-positive cell count for the stem cell mobilization effect of plerixafor in patients with multiple myeloma
Zhongqing LI ; Lin LUO ; Li ZHOU ; Qiaochuan LI ; Lianjin LIU ; Lingling SHI ; Yibin YAO ; Yuling XU ; Rongrong LIU ; Yinghua CHEN ; Yanye LIU ; Jun LUO
Journal of Leukemia & Lymphoma 2022;31(5):282-285
Objective:To explore the predictive value of peripheral blood CD34-positive cell count for the stem cell mobilization effect of plerixafor in patients with multiple myeloma (MM).Methods:The clinical data of 12 MM patients who used plerixafor for stem cell mobilization in the First Affiliated Hospital of Guangxi Medical University from December 2019 to February 2021 were retrospectively analyzed. The changes of peripheral blood CD34-positive cell count and the collection status of stem cell in all patients before and after the mobilization of plerixafor were analyzed.Results:Twelve patients were included in this study. These patients were in international staging system (ISS) stage Ⅱ-Ⅲ, and the induction therapy was mainly VRD regimen. The CD34-positive cell count was increased after the use of plerixafor in all patients no matter which mobilization strategies were used before plerixafor. The CD34-positive cell count was 3.63/μl (0.72-13.53/μl) and 32.11/μl (8.52-53.68/μl) before and after the use of plerixafor, and the difference was statistically significant ( Z = -0.40, P<0.001); the median increasing time was 11.50 times (1.61-23.71 times). The mobilization failure occurred in 1 patient. The CD34-positive cell count in his blood was less than 1/μl before the use of plerixafor; though increased 11.83 times after the use of plerixafor, the CD34-positive cell count was still less than 10/μl. Pearson analysis showed that among the patients with CD34-positive cell count less than 4/μl before the use of plerixafor, there was a positive correlation in peripheral blood CD34-positive cell count before and after the use of plerixafor ( r = 0.80, P = 0.032). Conclusions:The peripheral blood CD34-positive cell count has a certain predictive value for the stem cell mobilization effect of plerixafor in MM patients.